New trial offers hope to keep your bladder during cancer treatment
NCT ID NCT06290687
Summary
This study is testing whether removing only the cancerous part of the bladder, instead of the entire bladder, is a safe and effective treatment for muscle-invasive bladder cancer. About 40 participants will receive standard chemotherapy before and after surgery, followed by the partial bladder removal procedure. Researchers will track cancer recurrence, complications, and, importantly, how the treatment affects patients' quality of life and urinary function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE-INVASIVE BLADDER CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Glickman Urological and Kidney Institute, Cleveland Clinic, Case Comprehensive Cancer Center
RECRUITINGCleveland, Ohio, 44195, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.